Tomorrow! Join SITC for a focus on gastrointestinal cancers, Sept. 9 from 1–5 p.m. ET. Explore the latest advances in cancer immunotherapy for GI cancers during this live virtual program. Register today: https://www.sitcancer.org/edu/aci

Turn breakthrough ideas into biotech opportunities. Learn practical strategies for funding, pitching and building partnerships at Launching Biotech Startups: Funding, Pitching, Partnerships. Add this Pre-Conference Program to your #SITC26 experience! https://www.sitcancer.org/2026/register-now

Register to attend our 41st Annual Meeting and Pre-Conference Programs. #SITC26 brings together leaders for unmatched education, scientific exchange & networking with the scientists driving the field. Plan to attend in person or virtually! https://www.sitcancer.org/2026/home

Today, on #WorldLeukemiaDay, SITC joins the global leukemia community in raising awareness and advancing care for people living with leukemia. To that end, we are pleased that the new SITC acute leukemia CPG was accepted for publication in JITC and will be available soon! #WLD26

One week left to submit your Late-Breaking Abstracts – Clinical Only (LBAs) for #SITC26! Submit your cutting-edge research by Sept. 10, 2026. Additional oral presentation opportunities available! www.sitcancer.org/2026/abstract-lba

Soon we will select the Connect-a-Colleague Top Referrer for 2026! Will it be you? Learn how to refer colleagues to #SITC here: sitcancer.org/connect-a-colleague

The next webinar in the Computational Immuno-Oncology Series will take place on Sept. 15! Explore emerging computational approaches and their potential to advance cancer immunotherapy research. Register today: https://www.sitcancer.org/edu/webinars/computational

Stay in the know with #SITC! Explore our upcoming events, webinars, and important dates by looking at our calendar. Learn More: https://sitcancer.org/get-involved/events/calendar #Immunotherapy

Applications are now open for the SITC Sparkathon Class of 2027, focused on the next generation of cellular therapies! Connect, collaborate and grow your career. Apply today: sitcancer.org/career-development/sparkathon

Submit a Clinical Late-Breaking Abstract (LBA) by Sept. 10, for the opportunity to showcase your research and be considered for additional oral presentation opportunities. Learn more: www.sitcancer.org/2026/abstract-lba #SITC26

Manage adverse events in patients receiving IO for GI cancers! Join me on Sept. 9 for @sitcancer’s free virtual CME Advances in Cancer Immunotherapy: A Focus on Gastrointestinal Cancers program to address best practices. Learn more: https://www.sitcancer.org/edu/aci/gastro-cancers

One week to go! The 2026 SITC EU Immuno-Oncology Drug Development Summit is almost here. Join leading experts Sept. 3–4 in Lausanne, Switzerland, for two days of insights, innovation & collaboration shaping the future of IO drug development. Register now: www.sitcancer.org/eu-io-summit

See you in Phoenix Dr. @immunegirl.bsky.social!

Kristin Anderson, PhD@immunegirl.bsky.social · 3w ago

My first SITC Meeting was in 2017 - I haven't missed a single year since. Join me at #SITC26 for incredible networking & professional development opportunities AND the latest in IO research! Early reg. ends 8/24. Learn more, explore the schedule, and register: lnkd.in/e-HnNYAp See you in Phoenix!

Don’t miss the next webinar in the 2026 SITC Computational Immuno-Oncology Series! Join us Aug. 27 at 12–1 p.m. ET for Computation/Structure-Based Design of Immugen and Targeted Delivery of Biologics. Register now: https://www.sitcancer.org/edu/webinars/computational

#SITC26 early registration discount ends today! Take advantage of lower rates and attend our 41st Annual Meeting and Pre-Conference Programs. Celebrate 41 years of advancing IO at SITC 2026 held in Phoenix, AZ on Nov. 4–8. https://www.sitcancer.org/2026/home

Please join us in welcoming Dr. Hans-Georg Rammensee of University of Tübingen to the Academy of Immuno-Oncology. Thank you for your ongoing support to help advance SITC, the field, and the next generation of immuno-oncologists! Read his bio here: sitcancer.org/about/faio/rammensee-faio

One day left to receive the early registration rates for #SITC26. Join us either in person or virtually! We look forward to seeing you Nov. 4–8 in Phoenix, AZ! Register now for our early rates: https://www.sitcancer.org/2026/home

Congratulations to Dr. John M. Kirkwood of University of Pittsburgh and UPMC Hillman Cancer Center. We welcome you to the 2026 class of the FAIO, one of SITC’s most prestigious honors! Thank you for your dedication to the field of IO! Read his bio here: sitcancer.org/about/faio/kirkwood-faio

Only three weeks left to submit your Late-Breaking Abstracts – Clinical Only (LBAs) for #SITC26! Submit your cutting-edge research by Sept. 10. Additional oral presentation opportunities available. www.sitcancer.org/2026/abstract-lba

SITC is thrilled to announce the 2026 class of Fellows of the Academy of Immuno-Oncology (FAIO). Congratulations to Dr. Rachel Humphrey of Normunity, Inc. Thank you for continuing to advance the field of IO! Read her bio here: sitcancer.org/about/faio/humphrey-faio

Don’t miss the featured keynote at the SITC EU Immuno-Oncology Drug Development Summit! E. John Wherry, PhD, will highlight the intersection of immuno-oncology and autoimmunity. Join fellow IO leaders and experts in Lausanne, Sept. 3–4. www.sitcancer.org/edu/edu-sitc-biotech-initiative/eu-io-summit

It is an honor to welcome Dr. Kristen Hege of Independent Board of Directors Member to the 2026 class of Fellows of the Academy of Immuno-Oncology (FAIO), one of SITC’s most prestigious honors. Learn more about Dr. Hege: sitcancer.org/about/faio/hege-faio

Register for our 41st Annual Meeting and Pre-Conference Programs. #SITC26 provides a multidisciplinary educational & interactive environment focused on improving outcomes for cancer patients. Attend in person or virtually: https://www.sitcancer.org/2026/home

Physician-scientists by day, a funk-loving musical troupe by night—we asked the @sitcancer.bsky.social house band to craft a recommendation list that similarly blends these two worlds. So, pop on some music, crack open a journal, and enjoy the vibes. https://cancerletter.com/book-review/20260814_3/

Congratulations Dr. Nora Disis, CVI Director, who has been selected by @sitcancer.bsky.social to join the 2026 Fellows of the Academy of Immuno-Oncology. Learn more about this award and celebrate with us here: www.uwcvi.org/post/dr-nora... Headshot Credits: Lisa Stromme Warren

Welcome Dr. Mary (Nora) Disis of University of Washington to the 2026 class of the Academy of Immuno-Oncology. Congratulations on achieving one of SITC’s most prestigious honors! Read Dr. Disis’ bio and learn more here: sitcancer.org/about/faio/disis-faio

We are pleased to announce the 2026 class of Fellows of the Academy of Immuno-Oncology (FAIO)! The Academy recognizes individuals who have launched the field of cancer #immunotherapy into the breakthrough treatment it is today. Learn about the 2026 class: sitcancer.org/about/faio

What are The CheckPoints movin’ and groovin’ to this summer? Join the journal club with the best bops: We asked @sitcancer.bsky.social’s 13-piece band of medical musicians for the top papers and songs of the summer https://cancerletter.com/book-review/20260814_3/

Explore the investment trends driving the next generation of immuno-oncology innovation. Join the Session VII: Investment Panel at the 2026 SITC EU Immuno-Oncology Drug Development Summit to hear expert perspectives on advancing breakthrough therapies. sitcancer.org/eu-io-summit

Congratulations to Nicholas C. Love of University of Rochester Medical Center, recipient of the 2026-2027 National Cancer Institute Immunotherapy Fellowship, a 1-year, visiting #Fellowship! sitcancer.org/nci-immunotherapy-fellowship